- Type / Class
- Equity / Common Stock
- Shares outstanding
- 235,704,040
- Total 13F shares
- 9,523,198
- Share change
- +1,133,905
- Total reported value
- $57,439,000
- Price per share
- $5.95
- Number of holders
- 27
- Value change
- +$6,745,061
- Number of buys
- 18
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 000899104?
CUSIP 000899104 identifies ADMA - ADMA BIOLOGICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 000899104:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Aisling Capital LLC |
13F
|
Company |
1.5%
|
3,608,171
|
$29,190,000 | — | 31 Mar 2016 | |
| Biomark Capital Management Co. LLC |
13F
|
Company |
0.61%
|
1,433,304
|
$11,595,000 | — | 31 Mar 2016 | |
| Consonance Capital Management LP |
13F
|
Company |
0.45%
|
1,060,017
|
$8,576,000 | — | 31 Mar 2016 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.41%
|
964,193
|
$7,800,000 | — | 31 Mar 2016 | |
| FMR LLC |
13F
|
Company |
0.18%
|
423,100
|
$3,423,000 | — | 31 Mar 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.15%
|
359,499
|
$2,908,000 | — | 31 Mar 2016 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.06%
|
145,000
|
$1,173,000 | — | 31 Mar 2016 | |
| J. Goldman & Co LP |
13F
|
Company |
0.05%
|
120,976
|
$979,000 | — | 31 Mar 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.05%
|
119,959
|
$971,000 | — | 31 Mar 2016 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.02%
|
47,000
|
$380,000 | — | 31 Mar 2016 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.01%
|
35,000
|
$283,000 | — | 31 Mar 2016 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.01%
|
21,818
|
$177,000 | — | 31 Mar 2016 | |
| Spark Investment Management LLC |
13F
|
Company |
0.01%
|
13,800
|
$111,000 | — | 31 Mar 2016 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
13,195
|
$107,000 | — | 31 Mar 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
9,441
|
$76,000 | — | 31 Mar 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
5,456
|
$44,000 | — | 31 Mar 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
4,200
|
$33,000 | — | 31 Mar 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,193
|
$26,000 | — | 31 Mar 2016 | |
| Walleye Trading LLC |
13F
|
Company |
0%
|
900
|
$7,000 | — | 31 Mar 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
708
|
$6,000 | — | 31 Mar 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0%
|
563
|
$5,000 | — | 31 Mar 2016 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q2 2016
As of 30 Jun 2016,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,523,198 shares.
The largest 10 holders included
Aisling Capital LLC, Biomark Capital Management Co. LLC, Consonance Capital Management LP, Broadfin Capital, LLC, FMR LLC, PERCEPTIVE ADVISORS LLC, FRANKLIN RESOURCES INC, J. Goldman & Co LP, Weiss Multi-Strategy Advisers LLC, and Iguana Healthcare Management, LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
Q1 2016 holders
21
Q2 2016 holders
27
Holder diff
6
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.